Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

Completed · Phase 2

Conditions studied: Cancer Diagnosis, Diagnostic Techniques and Procedures, Diagnostic Imaging

In brief

This clinical trial studies how well positron emission tomography (PET)/computed tomography (CT) works compared to PET/magnetic resonance imaging (MRI) in evaluating patients with cancer. PET/CT and PET/MRI may determine which scanner is best for the patient's type of cancer and other types of cancers.

Key facts

Study ID

NCT03125629

Run by

Stanford University

People needed

53

Starts

2014-05-27

Expected to finish

2020-02-05

Last updated by the study team

2021-04-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Cancer diagnosis
• Capable of complying with study procedures
• Able to remain still for duration of imaging procedure (approximately 90 minutes total)
• Written informed consent

You may not qualify if…

• Pregnant or nursing
• Metallic implants
• Impaired renal function

Where it is running

• Stanford University, School of Medicine — Palo Alto, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.